Literature DB >> 17953232

Psychological factors, quality of life, and gastrointestinal symptoms in patients with erosive and non-erosive reflux disorder.

Zoltán Kovács1, Olga Kerékgyártó.   

Abstract

OBJECTIVE: Inconsistent findings are published regarding the psychosocial characteristics of erosive reflux disorder (ERD) and non-erosive reflux disorder (NERD) patients. The objective of this study was to determine the possible similarities and differences concerning psychosocial and somatic characteristics of these patients.
METHOD: Patients at a tertiary care center completed questionnaires on demographic characteristics, frequency of reflux symptoms, psychological distress, quality of life, and gastrointestinal symptoms. For comparative purposes, data from an age-matched healthy control group were obtained.
RESULTS: Higher proportion of female patients and a younger mean age was observed in NERD patients. No significant differences were detected regarding levels of psychological distress, gastrointestinal symptom severity, quality of life, and frequency of reflux symptoms. Both patient groups exhibited more severe psychological distress compared to healthy subjects. Only ERD patients demonstrated significant correlations between frequency of reflux symptoms and quality of life and severity of gastrointestinal symptoms. Compared to ERD patients, NERD patients showed stronger correlation between psychological distress and severity of reflux symptoms.
CONCLUSIONS: Reflux-like symptoms have a strong impact on patients' wellbeing, irrespective of endoscopical findings. The different patterns of associations between psychological, somatic and quality of life parameters in NERD and ERD patients can have theoretical and clinical implications.

Entities:  

Mesh:

Year:  2007        PMID: 17953232     DOI: 10.2190/1147-44K4-MMQQ-122X

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  7 in total

1.  Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease.

Authors:  Quinn K Lippmann; Seth D Crockett; Evan S Dellon; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

2.  Psychological Comorbidity and Chronic Heartburn: Which Is the Chicken and Which Is the Egg?

Authors:  Ronnie Fass; Shira S Fass
Journal:  Dig Dis Sci       Date:  2017-02-15       Impact factor: 3.199

3.  Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants.

Authors:  Kathleen W Wyrwich; Reema Mody; Lois M Larsen; Misun Lee; Neesha Harnam; Dennis A Revicki
Journal:  Qual Life Res       Date:  2010-02-27       Impact factor: 4.147

4.  Different Quality of Life Between GERD and Barrett's Esophagus (Am J Gastroenterol 2009;104:2695-2703).

Authors:  Su Youn Nam
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

5.  Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.

Authors:  Xiao-Ping Niu; Bao-Ping Yu; Yun-Dong Wang; Zhen Han; Shao-Fen Liu; Chi-Yi He; Guo-Zheng Zhang; Wan-Chun Wu
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

6.  Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.

Authors:  Fumiaki Kawara; Tsuyoshi Fujita; Yoshinori Morita; Atsushi Uda; Atsuhiro Masuda; Masaya Saito; Makoto Ooi; Tsukasa Ishida; Yasuyuki Kondo; Shiei Yoshida; Tatsuya Okuno; Yoshihiko Yano; Masaru Yoshida; Hiromu Kutsumi; Takanobu Hayakumo; Kazuhiko Yamashita; Takeshi Hirano; Midori Hirai; Takeshi Azuma
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

7.  Characteristics of symptom presentation and risk factors in patients with erosive esophagitis and nonerosive reflux disease.

Authors:  Shou-Wu Lee; Teng-Yu Lee; Han-Chung Lien; Sheng-Shun Yang; Hong-Zen Yeh; Chi-Sen Chang
Journal:  Med Princ Pract       Date:  2014-07-08       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.